Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the leqvio market grown in recent years?

In recent times, the size of the leqvio market has seen a XX (HCAGR). It is projected to expand from a worth of $XX million in 2024 to a value of $XX million in 2025, growing at a compound annual growth rate (CAGR) of XX%. The surge during the historic era is linked to factors such as elevated funding for the development of RNA-based drugs, an increase in expenditure on cholesterol control medication, higher investment in research and development as well as medicine development, heightened awareness about healthcare and a growing need for specialized medicines.

How is the leqvio market size expected to evolve during the forecast period?

Expectations for the Leqvio market size in the upcoming years indicate a substantial increase of XX% (FCAGR), reaching $XX million by 2029 thanks to a Compound Annual Growth Rate (CAGR) of XX%. Various factors contribute to this estimated growth within the forecasted period, including a global increase in cardiovascular diseases, a heightened awareness about the effectiveness of PCSK9 inhibitors, a rise in high cholesterol cases, an increase in the elderly population, and biologic drugs’ proliferation. Decisive trends to note in the same period are increased demand for improved hypercholesterolemia treatment, broadened applications through consistent research, relentless authorizations from regulatory authorities such as the FDA, advancements in biopharmaceutical research, and strides in drug development.

Get your leqvio market report here!

https://www.thebusinessresearchcompany.com/report/leqvio-global-market-report

Which key drivers are propelling the leqvio market’s growth?

The uptick in the occurrence of cardiovascular illnesses is anticipated to accelerate the expansion of the leqvio market. These conditions substantially affect the heart and blood vessels, leading to health problems such as heart attacks, high blood pressure, and strokes. Several contributing factors to these diseases include unhealthy eating habits, lack of physical activity, heavy alcohol consumption, diabetes, and aging. Leqvio functions by obstructing the PCSK9 protein, improving the liver’s capability to eliminate LDL cholesterol from the bloodstream. This action aids in lowering LDL levels and minimizing the threat of strokes, heart attacks, and other cardiovascular-related negatives. For example, data released by the British Heart Foundation in September 2024 stated that in the UK, nearly 7.6 million people are dealing with heart and circulatory diseases. This includes around 4 million men and 3.6 million women living with such conditions. Roughly 27% of all deaths in the UK, or over 170,000 deaths per annum, are due to these diseases. This amounts to almost 480 deaths daily, or one death every three minutes. As a result, the escalating incidence of cardiovascular diseases is fuelling the expansion of the Leqvio market.

What are the market segments in the leqvio industry?

The leqvio market covered in this report is segmented –

1) By Formulation: Injectable Formulation (Subcutaneous), Pre-Filled Syringes Or Auto-Injectors

2) By Indication: Treatment Of Hyperlipidemia, Management Of Atherosclerotic Cardiovascular Disease (ASCVD), Treatment Of Familial Hypercholesterolemia

3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients with Comorbid Conditions

4) By Distribution Channel: Direct Sales, Wholesalers and Distributors, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Cardiovascular Clinics, Specialty Pharmacies, Home Healthcare Providers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20143&type=smp

Which leading companies are shaping the growth of the leqvio market?

Major companies operating in the leqvio market include Novartis AG

What key trends are currently impacting the leqvio market’s development?

A significant trend in the leqvio market is the development of advanced injectable prescription drugs in order to provide treatments that last long and enhance patient compliance and outcomes. Injectable prescription drugs are treatments applied through injection designed to manage high cholesterol and decrease cardiovascular risks. These drugs are normally administered at consistent intervals to maintain continuous therapeutic impacts. For example, in July 2023, Novartis, a pharmaceutical firm based in Switzerland, obtained authorization from the US Food and Drug Administration (FDA) for a label update for Leqvio (inclisiran) that permitted its earlier use for patients with elevated LDL-C levels and higher heart disease risks, along with diet and statin therapy. Two doses per year, following two initial doses, lead to a 52% LDL-C reduction and the drug has shown to be effective for those patients who have not reached their LDL-C goals despite taking statin treatment. The label update underscores the solid safety and effectiveness data supported by the VictORION clinical trial program.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20143

Which geographic areas are influencing the growth of the leqvio market?

North America was the largest region in the leqvio market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leqvio market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Cholesterol Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Body Fat Reduction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/body-fat-reduction-global-market-report

Fatty Liver Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: